Veranova Appoints Joe Torres-Ocasio as SVP and Chief Operating Officer

Veranova, a developer and manufacturer of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, has appointed Joe Torres-Ocasio as Senior Vice President and Chief Operating Officer (COO).

Torres-Ocasio will lead Veranova’s global operations across its manufacturing network in Europe and North America, and will also oversee the company’s Engineering, Environmental Health & Safety (EHS) and Supply Chain/Operational Excellence functions.

“Joe’s deep operational expertise and proven leadership track record make him an exceptional addition to our Leadership Team” said Mike Riley, Chief Executive Officer of Veranova. “His ability to drive transformational change at scale across multiple technologies will be instrumental in driving operational excellence and delivering value to our customers and patients.”

Experience

Prior to joining Veranova, Torres-Ocasio served as Vice President of Global Operations for Catalent’s Biologics division, playing a role in transforming the performance of several key operations. His career also includes leadership roles at Baxter Healthcare International, where he led the turnaround and growth of critical sites before becoming a regional Vice President.

Torres-Ocasio began his career at Amgen as a manufacturing leader, where he led a high-impact Lean transformation. He later held senior operational roles at Immucor and Therapeutic Proteins International. He holds a dual BS degree in Chemical Engineering and Industrial Biotechnology from Universidad de Puerto Rico, as well as an MBA from Universidad Interamericana de Puerto Rico.